119 related articles for article (PubMed ID: 9641463)
1. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
Zhai QZ; Ingenito AJ
J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of intrahippocampal injection of dynorphin A(1-8), dynorphin A(1-13), dynorphin A(1-17), U-50,488H, and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Wang JQ; Ingenito AJ
Peptides; 1994 Jan; 15(1):125-32. PubMed ID: 7912425
[TBL] [Abstract][Full Text] [Related]
3. Sustained antihypertensive effects of chronic administration of two kappa-opioid agonists in spontaneously hypertensive rats.
Zhai QZ; Ingenito AJ
Am J Ther; 1997; 4(5-6):173-80. PubMed ID: 10423608
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cardiovascular responses to intra-hippocampal mu, delta and kappa opioid agonists in spontaneously hypertensive rats and isolation-induced hypertensive rats.
Shen S; Ingenito AJ
J Hypertens; 1999 Apr; 17(4):497-505. PubMed ID: 10404951
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats.
Gulati A; Bhargava HN
Eur J Pharmacol; 1988 Nov; 156(2):247-57. PubMed ID: 2853675
[TBL] [Abstract][Full Text] [Related]
6. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
7. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
8. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
9. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
Zhang WM; Wu S; Yu XC; Wang HX; Bian JS; Wong TM
J Mol Cell Cardiol; 1999 Feb; 31(2):355-62. PubMed ID: 10093048
[TBL] [Abstract][Full Text] [Related]
10. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831
[TBL] [Abstract][Full Text] [Related]
11. Effects of rat brain kappa 1- and kappa 2-opioid receptors after chronic treatment with non-peptide kappa-agonists.
McConnaughey MM; Zhai QZ; Ingenito AJ
J Pharm Pharmacol; 1998 Oct; 50(10):1121-5. PubMed ID: 9821658
[TBL] [Abstract][Full Text] [Related]
12. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
Kuzmin A; Sandin J; Terenius L; Ogren SO
J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
[TBL] [Abstract][Full Text] [Related]
13. Effects of kappa, sigma, and phencyclidine receptors agonists in rat tail arteries of spontaneously hypertensive rats.
Gao J; Bao WL; Sun FY; Zhang AZ
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):111-4. PubMed ID: 8010101
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
Childers SR; Xiao R; Vogt L; Sim LJ
Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
[TBL] [Abstract][Full Text] [Related]
15. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference.
Nestby P; Schoffelmeer AN; Homberg JR; Wardeh G; De Vries TJ; Mulder AH; Vanderschuren LJ
Psychopharmacology (Berl); 1999 Mar; 142(3):309-17. PubMed ID: 10208324
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats.
Yu XC; Wang HX; Zhang WM; Wong TM
J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190
[TBL] [Abstract][Full Text] [Related]
17. Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis.
Lishmanov YB; Maslov LN; Ugdyzhekova DS
Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):716-23. PubMed ID: 10499161
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
Bhargava HN; Gulati A; Ramarao P
Biochem Pharmacol; 1991 Jun; 42(1):25-9. PubMed ID: 1648922
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
20. Effect of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidin) cyclohexyl]-benzeneacetamide (U-50,488H), a kappa opioid receptor agonist, on intake of food in food-deprived and non-deprived spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Bhargava HN; Ramarao P; Richter CM; Bieniarz AA
Neuropharmacology; 1989 Jan; 28(1):63-7. PubMed ID: 2927580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
